Mobile Subthreshold Exercise Program for Concussion (M-STEP)

January 4, 2021 updated by: Sara PD Chrisman, MD MPH, Seattle Children's Hospital

Mobile Subthreshold Exercise Program (M-STEP) for Concussion

Non-randomized pilot intervention using mobile-administered sub-threshold exercise to treat youth with prolonged symptoms of concussion.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

6-week pilot study of a novel intervention for concussion, administering a sub-threshold exercise program in a mobile fashion using video conferencing and providing feedback using wrist-worn accelerometry and heart rate monitoring.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98104
        • Seattle Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Concussion diagnosed by a healthcare provider that occurred 2 weeks-6 months ago
  • Continued symptoms with at least 3 symptoms on the HBI and a score of 20+
  • No other issues that would preclude physical activity
  • Parents and youth are English-speaking

Exclusion Criteria:

- Already participating in >30 minutes of MVPA/day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: M-STEP
Mobile exercise intervention
Youth will be assessed using actigraphy at baseline, and will then be asked to exercise for 1) a duration of 10 minutes > MVPA at baseline with 2) HR>120 while being monitored by a Fitbit. Youth will be asked to exercise daily, and intensity and duration will be increased every few days for a goal of 60 minutes per day at a HR>140 (low end of MVPA). The intervention will be 6 weeks in duration.
Other Names:
  • Sub-threshold exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health Behavior Inventory (HBI), 21 item 0-3 likert, higher scores indicate more severe symptoms
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report questionnaire regarding concussive symptoms
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pediatric Quality of Life Inventory (PedsQL), 23 item 0-4 likert, converted to a 0-100 scale, higher scores indicate improved function
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report questionnaire regarding Health-related quality of life
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Change in Fear of pain questionnaire (FOPQ)-P/C, adapted for concussion, 24 item (child) and 23 item (parent) 0-4 likert, higher scores indicate greater fear-avoidance
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report questionnaire completed by parent and child regarding their fear of concussive symptoms and avoidance of activities that might produce concussive symptoms
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Change in Patient Health Questionnaire 9 (PHQ-9), 9 item 0-3 likert, higher scores indicate greater symptoms
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report questionnaire of depression symptoms
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Change in Adolescent Sleep Wake Scale (ASWS), 10-item 0-5 likert, higher scores indicate improved sleep quality
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report 10-item questionnaire regarding difficulty falling asleep, night wakenings and other sleep issues
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Change in Generalized anxiety disorder--7 item (GAD7), 7-item 0-3 likert, higher scores indicate more severe symptoms
Time Frame: Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Self-report questionnaire regarding anxiety symptoms (7-item)
Trajectory over 6 weeks (baseline, 3 weeks, 6 weeks)
Study Satisfaction Questionnaire
Time Frame: 6 weeks
8 item survey regarding satisfaction with study, 0-3 likert, higher scores indicate greater satisfaction
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sara PD Chrisman, MD, MPH, Seattle Children's Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2018

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

September 27, 2018

First Submitted That Met QC Criteria

September 28, 2018

First Posted (Actual)

October 1, 2018

Study Record Updates

Last Update Posted (Actual)

January 6, 2021

Last Update Submitted That Met QC Criteria

January 4, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Concussion

Clinical Trials on M-STEP

3
Subscribe